BioMarin Pharmaceutical, Inc. (BMRN)
56.21
-0.97
(-1.70%)
USD |
NASDAQ |
Jan 23, 16:00
56.75
+0.54
(+0.96%)
Pre-Market: 20:00
BioMarin Pharmaceutical EPS Diluted (TTM): 2.669 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Amicus Therapeutics, Inc. | -0.0446 |
| Gilead Sciences, Inc. | 6.456 |
| Merck & Co., Inc. | 7.560 |
| AbbVie, Inc. | 1.325 |
| Biogen, Inc. | 10.97 |